← 홈

Antibody · 자가면역·염증성

168개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-14 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 168개
AntibodySHOTFDACuratedFDABiologicAbbVieApproved

adalimumab (Humira, Hyrimoz, Amjevita)

Rheumatoid arthritis, psoriasis, Crohn's disease, ulcerative colitis, axial SpA · TNF-α

#TNF-#Antibody#Approved#FDA승인#바이오모아추천+5
효능 ORR 98.85%임상시험 420상태 APPROVED
AntibodySHOTFDACuratedFDABiologicNovartisApproved

secukinumab (Cosentyx)

Psoriasis, psoriatic arthritis, ankylosing spondylitis · IL-17A

#IL-17A#Antibody#Approved#FDA승인#바이오모아추천+5
효능 ORR 78.1%임상시험 153상태 APPROVED
AntibodySHOTFDACuratedFDABiologicAmgenApproved

etanercept (Enbrel, Erelzi)

RA, psoriasis, psoriatic arthritis, ankylosing spondylitis · TNF

#TNF#Antibody#Approved#FDA승인#바이오모아추천+5
효능 ORR 73.4%임상시험 117상태 APPROVED
AntibodySHOTFDACuratedFDABiologicJanssenApproved

ustekinumab (Stelara, Wezlana)

Psoriasis, psoriatic arthritis, Crohn's disease, ulcerative colitis · IL-12 / IL-23 (p40)

#IL-12IL-23p40#Antibody#Approved#FDA승인#바이오모아추천+5
효능 ORR 75%임상시험 116상태 APPROVED
AntibodySHOTFDACuratedFDABiologicAbbVieApproved

risankizumab (Skyrizi)

Psoriasis, psoriatic arthritis, Crohn's disease · IL-23 (p19)

#IL-23p19#Antibody#Approved#FDA승인#바이오모아추천+5
효능 ORR 90%임상시험 73상태 APPROVED
AntibodyHotJanssenApproved

Infliximab (Infliximab)

Cytokine Release Syndrome; Recurrent Multiple Myeloma · Crohn Disease

#CrohnDisease#Antibody#Approved#인기#항체+5
효능 ORR 54.5%임상시험 283상태 ACTIVE
AntibodyBNovartisApproved

AIN457 (Secukinumab, Secukinumab (AIN457))

Psoriatic Arthritis · Moderate to Severe Plaque-type Psoriasis

#ModeratetoSeverePlaque-typePsori#Antibody#Approved#인기#항체+4
효능 ORR 53%임상시험 98상태 ACTIVE
AntibodyBNovartisPhase 3

secukinumab (AIN457, AIN457 (secukinumab))

Asthma · Psoriatic Arthritis

#PsoriaticArthritis#Antibody#Phase3#인기#항체+4
효능 ORR 53%임상시험 95상태 ACTIVE
AntibodyAbbViePhase 3

Humira (Adalimumab, Adalimumab (Humira))

Ankylosing Spondylitis · Focal Glomerulosclerosis

#FocalGlomerulosclerosis#Antibody#Phase3#인기#항체+5
효능 ORR 98.4%임상시험 68상태 ACTIVE
AntibodyBelfast Health and Social Care …Approved

Golimumab (Golimumab)

Psoriatic Arthritis; Psoriasis · Chronic Nonbacterial Osteomyelitis

#ChronicNonbacterialOsteomyelitis#Antibody#Approved#인기#항체+5
효능 ORR 0.27%임상시험 64상태 DISCONTINUED
AntibodyJanssenderuxtecan in ovarian cance…Phase 2

Remicade (Infliximab, Infliximab (Remicade))

COPD; Cachexia · Kawasaki Disease

#KawasakiDisease#Antibody#Phase2#인기#항체+5
임상시험 64상태 ACTIVE
AntibodyJanssenderuxtecan in ovarian cance…Phase 3

infliximab (Remicade, Remicade (infliximab))

Uveitis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase3#인기#항체+5
임상시험 62상태 ACTIVE
AntibodyAbbVieApproved

adalimumab (Humira, Adalimumab treatment arm)

Psoriasis; Cardiovascular Diseases · Psoriasis

#Psoriasis#Antibody#Approved#인기#항체+5
효능 ORR 2%임상시험 56상태 ACTIVE
AntibodyEli Lilly and CompanyApproved

Ixekizumab (Ixekizumab)

Psoriasis; Atopic Dermatitis · Psoriatic Arthritis

#PsoriaticArthritis#Antibody#Approved#인기#항체+5
임상시험 53상태 RECRUITING
AntibodyNantes University HospitalPreclinical

Azathioprine + infliximab (Azathioprine + infliximab)

Crohn Disease · Crohn Disease

#CrohnDisease#Antibody#Preclinical#항체#면역항체+3
효능 ORR 6%임상시험 30상태 RECRUITING
AntibodyJanssenPreclinical

Anti TNF therapy including infliximab (Anti TNF therapy including infliximab)

Crohn's Disease; Ulcerative Colitis · Crohn's Disease

#CrohnsDisease#Antibody#Preclinical#항체#면역항체+4
임상시험 22상태 RECRUITING
AntibodystaleJanssenPhase 1

Topical infliximab (Topical infliximab)

Sterile Corneal Melt · Glaucoma Following Surgery

#GlaucomaFollowingSurgery#Antibody#Phase1#항체#면역항체+3
임상시험 11상태 ACTIVE
AntibodystaleAbbVieApproved

adalimumab (Humira, Humira (adalimumab))

Psoriasis · Ulcerative Colitis

#UlcerativeColitis#Antibody#Approved#항체#면역항체+3
효능 ORR 98.4%임상시험 6상태 ACTIVE
AntibodystaleAbbVieApproved

adalimumab (Humira, Adalimumab Ab)

Ankylosing Spondylitis · Ankylosing Spondylitis

#AnkylosingSpondylitis#Antibody#Approved#항체#면역항체+2
임상시험 5상태 ACTIVE
AntibodyUniversity of CalgaryApproved

ustekinumab (Stelara, Anti-IL12/23 or anti-IL23 - Ustekinumab)

Crohn Disease · Crohn Disease

#CrohnDisease#Antibody#Approved#항체#면역항체+2
임상시험 4상태 RECRUITING

1 / 9 페이지

← 이전다음 →